Advertisement
Advertisement

PCSA

PCSA logo

Processa Pharmaceuticals, Inc. Common

2.73
USD
Sponsored
-0.14
-4.88%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

2.80

+0.07
+2.71%

Processa Pharmaceuticals, Inc. Common Profile

About

Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.

Info & Links

CEO

George Ng

Headquarters

601 21ST STREET, SUITE 300
VERO BEACH, FL 32960, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.processapharmaceuticals.com

Auditor

Cherry Bekaert LLP

Share holders

187

Employees

12

Processa Pharmaceuticals, Inc. Common Statistics

Valuation Measures

Market Capitalization2

7.68M

Enterprise Value

5.99M

Enterprise Value/EBITDA(ttm)

-0.41

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.21

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-257.81%

Return on Invested Capital(ttm)

-263.92%

Return on Assets(ttm)

-191.10%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-14.47M

Net Income Available to Common(ttm)

-14.11M

Diluted EPS(ttm)

-34.00

Share Statistics

Beta (5Y Monthly)

0.89

52-Week Change

-60.15%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

2.60M

% Held by Insiders

2.40%

% Held by Institutions

91.93%

Balance Sheet

Total Cash(mrq)

1.69M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.54%

Quick Ratio(mrq)

2.54%

Book Value Per Share(mrq)

2.17

Cash Flow

Operating Cash Flow Per Share(ytd)

-8.70

Free Cash Flow(ytd)

-11.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement